Skip to main content
. 2021 Oct 5;7:131. doi: 10.1038/s41523-021-00337-2

Fig. 2. Changes in HbA1c at baseline and subsequent levels measured while on PGM therapy for patients with more than one measurement.

Fig. 2

(a) all patients (n = 72); (b) those with normal baseline HbA1c (n = 52); (c) elevated baseline HbA1c (n = 20).